HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency.

AbstractBACKGROUND:
The thrombin-generation assay has a variety of clinical uses, including diagnosis of thromboembolism-related disease, and particular profiles are associated with thrombophilic risk factors. The aim of this study was to evaluate the use of this assay in screening and identifying patients who require specific thrombophilic testing.
METHODS:
We used a 2-step approach to perform specific thrombophilic testing and thrombin-generation assays on 169 consecutive patients. The first step was to identify particular profiles of thrombin generation corresponding to each type of thrombophilic risk factor and to determine the pertinent variables related to thrombin generation. We then performed ROC curve analysis for each predefined variable to determine the relevant cutoffs for identification of patients in need of further testing (negative predictive value, 100%).
RESULTS:
Suggestive profiles were seen in factor V Leiden (n = 49) and prothrombin (n = 12) mutations and in protein S deficiency (n = 12). ROC curves showed that factor V Leiden may be excluded when the difference between lag times obtained in the absence and presence of activated protein C (APC) is >1.5 min and that prothrombin G20210A may also be excluded when the peak thrombin concentration is <or=426 nmol/L. In addition, protein S deficiency may be excluded when the percentage of APC-induced endogenous thrombin potential inhibition is >63%.
CONCLUSION:
The thrombin-generation assay represents a promising tool for screening thrombophilic risk factors, particularly in patients who are carriers of factor V Leiden or prothrombin G20210A mutations and patients with protein S deficiency.
AuthorsNathalie Hézard, Lobna Bouaziz-Borgi, Marie-Geneviève Remy, Philippe Nguyen
JournalClinical chemistry (Clin Chem) Vol. 52 Issue 4 Pg. 665-70 (Apr 2006) ISSN: 0009-9147 [Print] England
PMID16469858 (Publication Type: Journal Article)
Chemical References
  • factor V Leiden
  • Factor V
  • Prothrombin
  • Thrombin
Topics
  • Adult
  • Factor V (genetics)
  • Female
  • Humans
  • Male
  • Mass Screening
  • Mutation
  • Polymorphism, Single Nucleotide
  • Protein S Deficiency (blood, diagnosis)
  • Prothrombin (genetics)
  • ROC Curve
  • Risk Factors
  • Thrombin (biosynthesis)
  • Thrombophilia (diagnosis, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: